Corbus Pharmaceuticals (CRBP) Technical (Analysis) Reports Corbus Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Corbus Pharmaceuticals (CRBP)
Technical Analysis Report for USA stock CRBP Corbus Pharmaceuticals. Dated: 12 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock CRBP Corbus Pharmaceuticals then click here. or read Experts views on Corbus Pharmaceuticals or Forecast & share price targets of Corbus Pharmaceuticals
Corbus Pharmaceuticals Opened at 9.55 and Closed at: 9.70, which is 0.21% of previous session's close. It moved within a range of 9.50 and 10.16
The session was a Bullish session with an average volume of 497700, which is -910.01% of previous session's volumes.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 6 days back on short term averages
Support for tomorrow is 9.6 and resistance for tomorrow is 10.26
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 9.41, 9.13 resistance for tomorrow's hourly charts is 10.07, 10.45
10 Day SMA for Corbus Pharmaceuticals (CRBP) is 10.27 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Corbus Pharmaceuticals (CRBP) is 10.94 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Corbus Pharmaceuticals (CRBP) is 13.28 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 11.69 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Corbus Pharmaceuticals is 9.45 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Corbus Pharmaceuticals is at 10.94 and 200 DMA is at 9.45, while 50 DMA and 100 DMA are at 13.28 and 11.69 respectively
Corbus Pharmaceuticals (CRBP) moving average of 20 SMA is at 10.94 and 20 EMA is at 10.89
| Date | Closing Price | 20 SMA | 20 EMA |
| 12 Fri Dec | 9.70 | 10.94 | 10.89 |
| 11 Thu Dec | 9.68 | 11.01 | 11.02 |
| 10 Wed Dec | 10.26 | 11.09 | 11.16 |
| 09 Tue Dec | 10.10 | 11.09 | 11.25 |
| 08 Mon Dec | 10.37 | 11.11 | 11.37 |
| 05 Fri Dec | 10.24 | 11.12 | 11.47 |
Corbus Pharmaceuticals (CRBP) moving average of 50 SMA is at 13.28 and 50 EMA is at 11.78
| Date | Closing Price | 50 SMA | 50 EMA |
| 12 Fri Dec | 9.70 | 13.28 | 11.78 |
| 11 Thu Dec | 9.68 | 13.35 | 11.86 |
| 10 Wed Dec | 10.26 | 13.42 | 11.95 |
| 09 Tue Dec | 10.10 | 13.47 | 12.02 |
| 08 Mon Dec | 10.37 | 13.51 | 12.1 |
| 05 Fri Dec | 10.24 | 13.55 | 12.17 |
Corbus Pharmaceuticals (CRBP) moving average of 100 SMA is at 11.69 and 100 EMA is at 11.61
| Date | Closing Price | 100 SMA | 100 EMA |
| 12 Fri Dec | 9.70 | 11.69 | 11.61 |
| 11 Thu Dec | 9.68 | 11.68 | 11.65 |
| 10 Wed Dec | 10.26 | 11.67 | 11.69 |
| 09 Tue Dec | 10.10 | 11.65 | 11.72 |
| 08 Mon Dec | 10.37 | 11.64 | 11.75 |
| 05 Fri Dec | 10.24 | 11.62 | 11.78 |
Corbus Pharmaceuticals (CRBP) moving average of 200 SMA is at 9.45 and 200 EMA is at 13.59
| Date | Closing Price | 200 SMA | 200 EMA |
| 12 Fri Dec | 9.70 | 9.45 | 13.59 |
| 11 Thu Dec | 9.68 | 9.44 | 13.63 |
| 10 Wed Dec | 10.26 | 9.43 | 13.67 |
| 09 Tue Dec | 10.10 | 9.42 | 13.7 |
| 08 Mon Dec | 10.37 | 9.41 | 13.74 |
| 05 Fri Dec | 10.24 | 9.39 | 13.77 |
Penumbra Inc has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Penumbra Inc, about 23.79% more returns!
Xeris Pharmaceuticals has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Xeris Pharmaceuticals, about 12.24% more returns!
Verrica Pharmaceuticals has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Verrica Pharmaceuticals, about 113.91% more returns!
Iovance Biotherapeutics has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Iovance Biotherapeutics, about 1.45% more returns!
Insmed Inc has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Insmed Inc, about 14.34% more returns!
Inmune Bio has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Inmune Bio, about 53.93% more returns!
Corbus Pharmaceuticals has performed better than Helius Medical in short term. Holding Corbus Pharmaceuticals could be a better choice for now!
Genesis Healthcare has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Genesis Healthcare, about 16.01% more returns!
Fortress Biotech has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Fortress Biotech, about 24.21% more returns!
Esperion Therapeutics has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Esperion Therapeutics, about 45.14% more returns!
Corbus Pharmaceuticals has performed better than Entera Bio in short term. Holding Corbus Pharmaceuticals could be a better choice for now!
Dexcom Inc has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Dexcom Inc, about 27.71% more returns!
Cocrystal Pharma has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Cocrystal Pharma, about 14.32% more returns!
Cerus Corporation has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Cerus Corporation, about 46.95% more returns!
Axsome Therapeutics has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 18.45% more returns!
Atricure Inc has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Atricure Inc, about 41.19% more returns!
Arvinas Inc has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Arvinas Inc, about 31.4% more returns!
Corbus Pharmaceuticals has performed better than Aptevo Therapeutics in short term. Holding Corbus Pharmaceuticals could be a better choice for now!
Aclaris Therapeutics has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Aclaris Therapeutics, about 41.35% more returns!
Corbus Pharmaceuticals Technical analysis of indicators
Price action analysis of Corbus Pharmaceuticals (CRBP) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Corbus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Corbus Pharmaceuticals in short term and the sell signal is strong.
Corbus Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Corbus Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Corbus Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.86 and Corbus Pharmaceuticals CRBP stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Corbus Pharmaceuticals CRBP stock. Volume based technical analysis of Corbus Pharmaceuticals CRBP stock is negative.
Corbus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock CRBP Corbus Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CRBP Experts View which covers a lot of information including buying and selling signals
CRBP future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Corbus Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Corbus Pharmaceuticals (CRBP) Technical (Analysis) Reports Corbus Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


